SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027603
Filing Date
2023-08-10
Accepted
2023-08-10 16:50:24
Documents
83
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1716537
2 ex31-1.htm EX-31.1 20939
3 ex31-2.htm EX-31.2 20642
4 ex32-1.htm EX-32.1 9846
  Complete submission text file 0001493152-23-027603.txt   9611297

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ocx-20230630.xsd EX-101.SCH 75070
6 XBRL CALCULATION FILE ocx-20230630_cal.xml EX-101.CAL 77401
7 XBRL DEFINITION FILE ocx-20230630_def.xml EX-101.DEF 383042
8 XBRL LABEL FILE ocx-20230630_lab.xml EX-101.LAB 579190
9 XBRL PRESENTATION FILE ocx-20230630_pre.xml EX-101.PRE 496059
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1650067
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 231160362
SIC: 2835 In Vitro & In Vivo Diagnostic Substances